Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Surgery Partners (NASDAQ: SGRY) shareholders watched the stock drop sharply in early March 2026 after Q4 2025 results and FY 2026 outlook both fell short...
-
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Freshpet, Inc. (NASDAQ: FRPT) shareholders who lost money are urged to act now. Freshpet is altering its advertising following a National Advertising...
-
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Investors in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) lost approximately 70% of their holdings after the FDA issued a Complete Response Letter for...
-
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Shareholders of Immutep Ltd. (NASDAQ: IMMP) who lost money are urged to act now. On January 30, 2026, Immutep filed a 6-K stating that completion of the...
-
Levi & Korsinsky, LLP: Grail (GRAL) Guided to 2030 Cash Runway While Key Trial Risk Went Unaddressed
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- NEW YORK, March 26, 2026 -- Grail, Inc. (NASDAQ: GRAL) lost approximately 50% of its market value after disclosing that the NHS Galleri randomized trial...
-
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Gossamer Bio, Inc. (NASDAQ: GOSS) shareholders suffered significant losses when the Company disclosed that its Phase 3 PROSERA study of seralutinib...
-
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Theravance Biopharma (NASDAQ: TBPH) shareholders lost approximately 26% when shares collapsed on March 3, 2026. In the quarters leading up to that drop,...
-
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- On February 18, 2026, Insulet Corp. (NASDAQ: PODD) CEO Ashley McEvoy told investors on the Q4 2025 earnings call that "our results in the fourth quarter...
-
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Investors in G-III Apparel Group, Ltd. (NASDAQ: GIII) lost more than 11% of their share value on March 12, 2026, after the company reported full-year...
-
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Avis Budget Group (NASDAQ: CAR) reported adjusted EBITDA growth of 11% for Q4 2025. Under GAAP, the Company posted a net loss of $856 million....